Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Oxymetazoline by Levation Pharma for Ptosis: Likelihood of Approval
Oxymetazoline is under clinical development by Levation Pharma and currently in Phase II for Ptosis. According to GlobalData, Phase II...